Legal & General Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-86,244
| Closed | -$2.04M | – | 3382 |
|
|
2023
Q4 | $2.04M | Buy |
86,244
+3,055
| +4% | +$72.2K | ﹤0.01% | 1951 |
|
|
2023
Q3 | $1.24M | Buy |
83,189
+6,232
| +8% | +$92.9K | ﹤0.01% | 2111 |
|
|
2023
Q2 | $843K | Buy |
76,957
+40,372
| +110% | +$442K | ﹤0.01% | 2284 |
|
|
2023
Q1 | $319K | Buy |
+36,585
| New | +$319K | ﹤0.01% | 2437 |
|
|
2022
Q2 | – | Sell |
-7,302
| Closed | -$23K | – | 3704 |
|
|
2022
Q1 | $23K | Buy |
7,302
+1,744
| +31% | +$5.49K | ﹤0.01% | 3207 |
|
|
2021
Q4 | $19K | Hold |
5,558
| – | – | ﹤0.01% | 3298 |
|
|
2021
Q3 | $20K | Hold |
5,558
| – | – | ﹤0.01% | 3284 |
|
|
2021
Q2 | $24K | Sell |
5,558
-3,899
| -41% | -$16.8K | ﹤0.01% | 3237 |
|
|
2021
Q1 | $43K | Hold |
9,457
| – | – | ﹤0.01% | 2864 |
|
|
2020
Q4 | $54K | Buy |
9,457
+3,351
| +55% | +$19.1K | ﹤0.01% | 2781 |
|
|
2020
Q3 | $44K | Sell |
6,106
-2,397
| -28% | -$17.3K | ﹤0.01% | 2741 |
|
|
2020
Q2 | $30K | Sell |
8,503
-4,931
| -37% | -$17.4K | ﹤0.01% | 2902 |
|
|
2020
Q1 | $20K | Sell |
13,434
-2,970
| -18% | -$4.42K | ﹤0.01% | 2921 |
|
|
2019
Q4 | $32K | Buy |
16,404
+2,658
| +19% | +$5.19K | ﹤0.01% | 3019 |
|
|
2019
Q3 | $71K | Hold |
13,746
| – | – | ﹤0.01% | 2627 |
|
|
2019
Q2 | $98K | Buy |
13,746
+3,151
| +30% | +$22.5K | ﹤0.01% | 2540 |
|
|
2019
Q1 | $140K | Buy |
10,595
+654
| +7% | +$8.64K | ﹤0.01% | 2404 |
|
|
2018
Q4 | $78K | Hold |
9,941
| – | – | ﹤0.01% | 2534 |
|
|
2018
Q3 | $110K | Hold |
9,941
| – | – | ﹤0.01% | 2485 |
|
|
2018
Q2 | $134K | Buy |
+9,941
| New | +$134K | ﹤0.01% | 2407 |
|